ROYCE & ASSOCIATES LP - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 187 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.83 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$653,000
+10.7%
69,057
+4.9%
0.01%
+16.7%
Q2 2020$590,000
+40.8%
65,8150.0%0.01%0.0%
Q1 2020$419,000
-24.0%
65,8150.0%0.01%
+20.0%
Q4 2019$551,000
-7.6%
65,8150.0%0.01%
-16.7%
Q3 2019$596,000
-15.9%
65,8150.0%0.01%0.0%
Q2 2019$709,000
+12.9%
65,8150.0%0.01%
+20.0%
Q1 2019$628,000
-37.0%
65,815
-24.2%
0.01%
-44.4%
Q4 2018$997,000
-58.2%
86,815
-38.3%
0.01%
-43.8%
Q3 2018$2,387,000
-34.3%
140,815
-45.0%
0.02%
-36.0%
Q2 2018$3,633,000
+3.5%
255,815
+38.5%
0.02%0.0%
Q1 2018$3,509,000
-35.4%
184,665
-44.2%
0.02%
-30.6%
Q4 2017$5,428,000
-24.4%
330,965
-30.8%
0.04%
-25.0%
Q3 2017$7,177,000
+8.6%
478,465
-36.3%
0.05%
+9.1%
Q2 2017$6,610,000
+69.2%
751,1000.0%0.04%
+69.2%
Q1 2017$3,906,000
+70.5%
751,1000.0%0.03%
+73.3%
Q4 2016$2,291,000
-7.7%
751,100
+40.1%
0.02%
-6.2%
Q3 2016$2,482,000
-6.0%
536,100
+17.5%
0.02%
-5.9%
Q2 2016$2,641,000
-4.3%
456,1000.0%0.02%0.0%
Q1 2016$2,759,000
-3.2%
456,100
+46.1%
0.02%0.0%
Q4 2015$2,849,000
+138.2%
312,100
+47.1%
0.02%
+183.3%
Q3 2015$1,196,000212,1000.01%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Alexandria Capital, LLC 1,003,725$15,663,0001.66%
Golden State Equity Partners 123,817$1,932,0001.33%
Rhenman & Partners Asset Management AB 821,888$12,826,0001.05%
WASATCH ADVISORS LP 10,072,381$157,180,0000.77%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 29,636$462,0000.73%
Ceeto Capital Group, LLC 80,000$1,248,0000.63%
EMC Capital Management 48,992$765,0000.58%
Fort Sheridan Advisors LLC 71,173$1,111,0000.54%
Vanguard Capital Wealth Advisors 34,680$584,0000.54%
Casdin Capital, LLC 1,080,000$16,853,0000.50%
View complete list of SANGAMO THERAPEUTICS INC shareholders